<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Atkins</surname>
    <given-names>HL</given-names>
   </name>
   <name>
    <surname>Bowman</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Allan</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Anstee</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Arnold</surname>
    <given-names>DL</given-names>
   </name>
   <name>
    <surname>Bar-Or</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial</article-title>. 
  <source>Lancet</source> (
  <year>2016</year>) 
  <volume>388</volume>(
  <issue>10044</issue>):
  <fpage>576</fpage>â€“
  <lpage>85</lpage>.
  <pub-id pub-id-type="doi">10.1016/S0140-6736(16)30169-6</pub-id>
  <?supplied-pmid 27291994?>
  <pub-id pub-id-type="pmid">27291994</pub-id>
 </mixed-citation>
</ref>
